Decipher Labs Ltd.

Financial

	Decipher Labs	Beryl Drugs	Venmax Drugs&Pharma
Operational Metrics
Financials
5 yr Average ROE	9.38 %	2.54 %	-44.32 %
5yr average Equity Multiplier	2.01	2.23	-0.19
5yr Average Asset Turnover Ratio	1.29	1.08	0.32
5yr Avg Net Profit Margin	2.8 %	0.66 %	-30.94 %
Price to Book	0.56	1.34	0.0
P/E	53.25	149.36	0.0
5yr Avg Cash Conversion Cycle	-270.54 Days	-619.24 Days	0.0
Inventory Days	1.26 Days	36.1 Days	24.83 Days
Days Receivable	89.79 Days	98.89 Days	0.0
Days Payable	3118.67 Days	969.29 Days	189.56 Days
5yr Average Interest Coverage Ratio	4.09	1.68	-318.36
5yr Avg ROCE	12.42 %	5.73 %	-45.33 %
5yr Avg Operating Profit Margin	1.0 %	7.19 %	-50.41 %
5 yr average Debt to Equity	0.46	0.64	-0.64
5yr CAGR Net Profit	n/a	72.78 %	n/a
5yr Average Return on Assets	3.79 %	1.31 %	187.49 %
Shareholdings
Promoter Holding	16.43 %	26.38 %	23.13 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-17.76 %	1.46 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0